Lumosag, Linda .

HRN: 27-20-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2025
CEFTRIAXONE 1G (VIAL)
05/27/2025
06/03/2025
IV
2G
OD
UTI
Waiting Final Action 
06/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/05/2025
06/12/2025
IV
4.5g
Q8
Fever Of Malignancy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: